Clinical trial
Adjuvanted Influenza Vaccine Evaluation in Kidney Transplant Recipients(AdVEnTR)
NCT01584908 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adjuvanted Influenza Vaccine Evaluation in Kidney Transplant Recipients(AdVEnTR)
- Lead sponsor
- University of Alberta
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- November 30, 2014
- Enrollment
- 68 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
influenza